Global Sexually Transmitted Diseases (STD) Testing Market Size study & Forecast, by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), and Other Diseases) and Location of Testing (Laboratory Testing, and Point-of-care (POC) Testing) and Regional Analysis, 2022-2029
Global Sexually Transmitted Diseases (STD) Testing Market is valued approximately USD 96.06 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Sexually Transmitted Diseases (STD) refer to infection transmitted from an infected person to an uninfected person through sextual contact. STDs are caused by bacteria, and viruses. Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), and Human Immunodeficiency Virus among others are different kind of STDs. The increasing prevalence of STDs worldwide and favorable reimbursement policies for STDs as well as strategic initiatives from leading market players are key factors accelerating the market growth.
According to the World Health Organization (WHO) estimates – in 2020, globally around 374 million new cases of STIs were reported. In addition, the most prevalent type of infection was chlamydia with 129 million cases, followed by gonorrhoea with 82 million cases, syphilis with 7.1 million cases and trichomoniasis with 156 million cases. Also, growing healthcare infrastructure in the developing regions and rising patient awareness towards STD prevalence would create lucrative growth prospectus for the market over the forecast period. However, the high cost associated with testing equipment and social stigma associated with STDs impede the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Sexually Transmitted Diseases (STD) Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to factors such as presence of leading market players as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising prevalence of STDs as well as increasing number of favorable initiatives from government authorities in terms of awareness campaigns and reimbursement policies in the region.
Major market player included in this report are:
Abbott Laboratories
Becton Dickinson Company
Biomйrieux, Inc.
Bio-Rad Laboratories Inc.
Danaher Corporation
Diasorin Molecular Llc
Hologic Inc.
Orasure Technologies, Inc.
Roche Holdings Ag
Thermo Fisher Scientific (Affymetrix)
Recent Developments in the Market:
In June 2019, Quest Diagnostics, launched three laboratory testing packages for sexually transmitted diseases (STDs). The package would cover chlamydia, gonorrhea, and syphilis, would be available for online purchase by individuals across the United States.
In April 2022, USA based Chiricahua Community Health Centers, Inc. (CCHCI) entered in a collaboration with The Body Agency Collective (TBAC) and Visby Medical, Inc., to enhance the diagnosis and treatment of sexually transmitted infection (STI). Under this project the community health center would utilize PCR diagnostic device, the Sexual Health Click Test to test STIs in women within 30 minutes.
Global Sexually Transmitted Diseases (STD) Testing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Disease Type, Location of Testing, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease Type
Chlamydia
Gonorrhea
Herpes Simplex Virus
Syphilis
Human Papillomavirus (HPV)
Human Immunodeficiency Virus (HIV)
Other Diseases
By Location of Testing
Laboratory Testing
Point-of-care (POC) Testing)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
According to the World Health Organization (WHO) estimates – in 2020, globally around 374 million new cases of STIs were reported. In addition, the most prevalent type of infection was chlamydia with 129 million cases, followed by gonorrhoea with 82 million cases, syphilis with 7.1 million cases and trichomoniasis with 156 million cases. Also, growing healthcare infrastructure in the developing regions and rising patient awareness towards STD prevalence would create lucrative growth prospectus for the market over the forecast period. However, the high cost associated with testing equipment and social stigma associated with STDs impede the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Sexually Transmitted Diseases (STD) Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to factors such as presence of leading market players as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising prevalence of STDs as well as increasing number of favorable initiatives from government authorities in terms of awareness campaigns and reimbursement policies in the region.
Major market player included in this report are:
Abbott Laboratories
Becton Dickinson Company
Biomйrieux, Inc.
Bio-Rad Laboratories Inc.
Danaher Corporation
Diasorin Molecular Llc
Hologic Inc.
Orasure Technologies, Inc.
Roche Holdings Ag
Thermo Fisher Scientific (Affymetrix)
Recent Developments in the Market:
In June 2019, Quest Diagnostics, launched three laboratory testing packages for sexually transmitted diseases (STDs). The package would cover chlamydia, gonorrhea, and syphilis, would be available for online purchase by individuals across the United States.
In April 2022, USA based Chiricahua Community Health Centers, Inc. (CCHCI) entered in a collaboration with The Body Agency Collective (TBAC) and Visby Medical, Inc., to enhance the diagnosis and treatment of sexually transmitted infection (STI). Under this project the community health center would utilize PCR diagnostic device, the Sexual Health Click Test to test STIs in women within 30 minutes.
Global Sexually Transmitted Diseases (STD) Testing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Disease Type, Location of Testing, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease Type
Chlamydia
Gonorrhea
Herpes Simplex Virus
Syphilis
Human Papillomavirus (HPV)
Human Immunodeficiency Virus (HIV)
Other Diseases
By Location of Testing
Laboratory Testing
Point-of-care (POC) Testing)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Sexually Transmitted Diseases (STD) Testing Market, by Region, 2019-2029 (USD Billion)
1.2.2. Sexually Transmitted Diseases (STD) Testing Market, by Disease Type, 2019-2029 (USD Billion)
1.2.3. Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET DYNAMICS
3.1. Sexually Transmitted Diseases (STD) Testing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of STDs worldwide.
3.1.1.2. Favourable reimbursement policies for STDs
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High cost associated with testing equipment.
3.1.2.2. Social stigma associated with STDs
3.1.3. Market Opportunities
3.1.3.1. Growing healthcare infrastructure in the developing regions.
3.1.3.2. Rising patient awareness towards STD prevalence.
CHAPTER 4. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET, BY DISEASE TYPE
6.1. Market Snapshot
6.2. Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, Performance - Potential Analysis
6.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
6.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
6.4.1. Chlamydia
6.4.2. Gonorrhea
6.4.3. Herpes simplex virus
6.4.4. Syphilis
6.4.5. Human papillomavirus (HPV)
6.4.6. Other diseases (human immunodeficiency virus (HIV), chancroid, trichomoniasis, and hepatitis B)
CHAPTER 7. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET, BY LOCATION OF TESTING
7.1. Market Snapshot
7.2. Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, Performance - Potential Analysis
7.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Location of Testing 2019-2029 (USD Billion)
7.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
7.4.1. Laboratory testing
7.4.2. Point of care (POC) testing
CHAPTER 8. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET, REGIONAL ANALYSIS
8.1. Sexually Transmitted Diseases (STD) Testing Market, Regional Market Snapshot
8.2. North America Sexually Transmitted Diseases (STD) Testing Market
8.2.1. U.S. Sexually Transmitted Diseases (STD) Testing Market
8.2.1.1. Disease Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Location of Testing breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Sexually Transmitted Diseases (STD) Testing Market
8.3. Europe Sexually Transmitted Diseases (STD) Testing Market Snapshot
8.3.1. U.K. Sexually Transmitted Diseases (STD) Testing Market
8.3.2. Germany Sexually Transmitted Diseases (STD) Testing Market
8.3.3. France Sexually Transmitted Diseases (STD) Testing Market
8.3.4. Spain Sexually Transmitted Diseases (STD) Testing Market
8.3.5. Italy Sexually Transmitted Diseases (STD) Testing Market
8.3.6. Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
8.4. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Snapshot
8.4.1. China Sexually Transmitted Diseases (STD) Testing Market
8.4.2. India Sexually Transmitted Diseases (STD) Testing Market
8.4.3. Japan Sexually Transmitted Diseases (STD) Testing Market
8.4.4. Australia Sexually Transmitted Diseases (STD) Testing Market
8.4.5. South Korea Sexually Transmitted Diseases (STD) Testing Market
8.4.6. Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
8.5. Latin America Sexually Transmitted Diseases (STD) Testing Market Snapshot
8.5.1. Brazil Sexually Transmitted Diseases (STD) Testing Market
8.5.2. Mexico Sexually Transmitted Diseases (STD) Testing Market
8.6. Rest of The World Sexually Transmitted Diseases (STD) Testing Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Becton Dickinson Company
9.2.3. Biomйrieux, Inc.
9.2.4. Bio-Rad Laboratories Inc.
9.2.5. Danaher Corporation
9.2.6. Diasorin Molecular LLC
9.2.7. Hologic Inc.
9.2.8. Orasure Technologies, Inc.
9.2.9. Roche Holdings Ag
9.2.10. Thermo Fisher Scientific (Affymetrix)
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Sexually Transmitted Diseases (STD) Testing Market, by Region, 2019-2029 (USD Billion)
1.2.2. Sexually Transmitted Diseases (STD) Testing Market, by Disease Type, 2019-2029 (USD Billion)
1.2.3. Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET DYNAMICS
3.1. Sexually Transmitted Diseases (STD) Testing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of STDs worldwide.
3.1.1.2. Favourable reimbursement policies for STDs
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High cost associated with testing equipment.
3.1.2.2. Social stigma associated with STDs
3.1.3. Market Opportunities
3.1.3.1. Growing healthcare infrastructure in the developing regions.
3.1.3.2. Rising patient awareness towards STD prevalence.
CHAPTER 4. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET, BY DISEASE TYPE
6.1. Market Snapshot
6.2. Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, Performance - Potential Analysis
6.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
6.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
6.4.1. Chlamydia
6.4.2. Gonorrhea
6.4.3. Herpes simplex virus
6.4.4. Syphilis
6.4.5. Human papillomavirus (HPV)
6.4.6. Other diseases (human immunodeficiency virus (HIV), chancroid, trichomoniasis, and hepatitis B)
CHAPTER 7. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET, BY LOCATION OF TESTING
7.1. Market Snapshot
7.2. Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, Performance - Potential Analysis
7.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Location of Testing 2019-2029 (USD Billion)
7.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
7.4.1. Laboratory testing
7.4.2. Point of care (POC) testing
CHAPTER 8. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET, REGIONAL ANALYSIS
8.1. Sexually Transmitted Diseases (STD) Testing Market, Regional Market Snapshot
8.2. North America Sexually Transmitted Diseases (STD) Testing Market
8.2.1. U.S. Sexually Transmitted Diseases (STD) Testing Market
8.2.1.1. Disease Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Location of Testing breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Sexually Transmitted Diseases (STD) Testing Market
8.3. Europe Sexually Transmitted Diseases (STD) Testing Market Snapshot
8.3.1. U.K. Sexually Transmitted Diseases (STD) Testing Market
8.3.2. Germany Sexually Transmitted Diseases (STD) Testing Market
8.3.3. France Sexually Transmitted Diseases (STD) Testing Market
8.3.4. Spain Sexually Transmitted Diseases (STD) Testing Market
8.3.5. Italy Sexually Transmitted Diseases (STD) Testing Market
8.3.6. Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
8.4. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Snapshot
8.4.1. China Sexually Transmitted Diseases (STD) Testing Market
8.4.2. India Sexually Transmitted Diseases (STD) Testing Market
8.4.3. Japan Sexually Transmitted Diseases (STD) Testing Market
8.4.4. Australia Sexually Transmitted Diseases (STD) Testing Market
8.4.5. South Korea Sexually Transmitted Diseases (STD) Testing Market
8.4.6. Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
8.5. Latin America Sexually Transmitted Diseases (STD) Testing Market Snapshot
8.5.1. Brazil Sexually Transmitted Diseases (STD) Testing Market
8.5.2. Mexico Sexually Transmitted Diseases (STD) Testing Market
8.6. Rest of The World Sexually Transmitted Diseases (STD) Testing Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Becton Dickinson Company
9.2.3. Biomйrieux, Inc.
9.2.4. Bio-Rad Laboratories Inc.
9.2.5. Danaher Corporation
9.2.6. Diasorin Molecular LLC
9.2.7. Hologic Inc.
9.2.8. Orasure Technologies, Inc.
9.2.9. Roche Holdings Ag
9.2.10. Thermo Fisher Scientific (Affymetrix)
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Sexually Transmitted Diseases (STD) Testing Market, report scope
TABLE 2. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Disease Type 2019-2029 (USD Billion)
TABLE 4. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Location of Testing 2019-2029 (USD Billion)
TABLE 5. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Sexually Transmitted Diseases (STD) Testing Market
TABLE 70. List of primary sources, used in the study of global Sexually Transmitted Diseases (STD) Testing Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Sexually Transmitted Diseases (STD) Testing Market, report scope
TABLE 2. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Disease Type 2019-2029 (USD Billion)
TABLE 4. Global Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by Location of Testing 2019-2029 (USD Billion)
TABLE 5. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Sexually Transmitted Diseases (STD) Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Sexually Transmitted Diseases (STD) Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Sexually Transmitted Diseases (STD) Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Sexually Transmitted Diseases (STD) Testing Market
TABLE 70. List of primary sources, used in the study of global Sexually Transmitted Diseases (STD) Testing Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Sexually Transmitted Diseases (STD) Testing Market, research methodology
FIG 2. Global Sexually Transmitted Diseases (STD) Testing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Sexually Transmitted Diseases (STD) Testing Market, key trends 2021
FIG 5. Global Sexually Transmitted Diseases (STD) Testing Market, growth prospects 2022-2029
FIG 6. Global Sexually Transmitted Diseases (STD) Testing Market, porters 5 force model
FIG 7. Global Sexually Transmitted Diseases (STD) Testing Market, pest analysis
FIG 8. Global Sexually Transmitted Diseases (STD) Testing Market, value chain analysis
FIG 9. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Sexually Transmitted Diseases (STD) Testing Market, regional snapshot 2019 & 2029
FIG 15. North America Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 16. Europe Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 19. Global Sexually Transmitted Diseases (STD) Testing Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Sexually Transmitted Diseases (STD) Testing Market, research methodology
FIG 2. Global Sexually Transmitted Diseases (STD) Testing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Sexually Transmitted Diseases (STD) Testing Market, key trends 2021
FIG 5. Global Sexually Transmitted Diseases (STD) Testing Market, growth prospects 2022-2029
FIG 6. Global Sexually Transmitted Diseases (STD) Testing Market, porters 5 force model
FIG 7. Global Sexually Transmitted Diseases (STD) Testing Market, pest analysis
FIG 8. Global Sexually Transmitted Diseases (STD) Testing Market, value chain analysis
FIG 9. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Sexually Transmitted Diseases (STD) Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Sexually Transmitted Diseases (STD) Testing Market, regional snapshot 2019 & 2029
FIG 15. North America Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 16. Europe Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Sexually Transmitted Diseases (STD) Testing Market 2019 & 2029 (USD Billion)
FIG 19. Global Sexually Transmitted Diseases (STD) Testing Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
